SYRE ▼ -1.4% - Spyre Therapeutics, Inc. $SYRE - Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026 18-OCT-2026 09:30 AM ET